Prophylactic cancer vaccination by targeting functional non-self

References

• Centers for Disease Control and Prevention. Ten great public health achievements—United States, 1900–1999. Morb Mortal Wkly Rep. 1999;48:241–3.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children—United States, 1990–1998. Morb Mortal Wkly Rep. 1999;48:243–8.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Recommendations and guidelines 2011 child and adolescent immunization schedules. Available at: http://www.cdc.gov/vaccines/recs/schedules/child-schedule.htm (Last accessed 11 March 2011).
   Google Scholar
• National Network for Immunization Information (NNii). Vaccines: Hib. 2007. Available at: http://www.immunizationinfo.org/vaccines/haemophilus-influenzae-type-b-hib (Last accessed 11 March 2011).
   Google Scholar
• National Network for Immunization Information (NNii). Vaccines: diphtheria, tetanus, pertussis (DTaP). 2009. Available at: http://www.immunizationinfo.org/vaccines/tetanus (Last accessed 11 March 2011).
   Google Scholar
• Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155–63.
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, ; Costa Rican HPV Vaccine Trial Group. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743–53.
   PubMed Web of Science ®Google Scholar
• Jackson AC. Rabies virus infection: an update. Neurovirol. 2003;9:253–8.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC. Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004;10: 909–15.
   PubMed Web of Science ®Google Scholar
• Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, ; IMPACT Study Investigators. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411–22.
   PubMed Web of Science ®Google Scholar
• McCaughtry TM, Baldwin TA, Wilken MS, Hogquist KA. Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla. J Exp Med. 2008; 205: 2575–84.
   PubMedGoogle Scholar
• Nitta T, Murata S, Ueno T, Tanaka K, Takahama Y. Thymic microenvironments for T-cell repertoire formation. Adv Immunol. 2008;99:59–94.
   PubMedGoogle Scholar
• Rubin SC, Finstad CL, Federici MG, Scheiner L, Lloyd KO, Hoskins WJ. Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer. Cancer. 1994;73:1456–9.
   PubMed Web of Science ®Google Scholar
• Serrano-Olvera A, Duenas-Gonzalez A, Gallardo-Rincon D, Candelaria M, De la Garza-Salazar J. Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer. Cancer Treat Rev. 2006;32:180–90.
   PubMed Web of Science ®Google Scholar
• Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, . The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist. 2003;8: 307–25.
   PubMed Web of Science ®Google Scholar
• Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J. Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res. 2003;9:1837–49.
   PubMed Web of Science ®Google Scholar
• Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res. 2008; 68:861–9.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267–96.
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, . Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci U S A. 1994; 91:3515–9.
   PubMed Web of Science ®Google Scholar
• Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, . Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850–4.
   PubMed Web of Science ®Google Scholar
• Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, . Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363:711–23.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Vaccines, Blood, and Biologics. Approval Letter—Provenge. 29 April 2010. Available at: http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm210215.htm (Last accessed 11 March 2011).
   Google Scholar
• Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, . Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol. 2006;24: 3089–94.
   PubMed Web of Science ®Google Scholar
• Cheng MH, Shum AK, Anderson MS. What's new in the Aire? Trends Immunol. 2007;28:321–7.
   PubMedGoogle Scholar
• Tykocinski LO, Sinemus A, Kyewski B. The thymus medulla slowly yields its secrets. Ann NY Acad Sci. 2008;1143: 105–22.
   PubMedGoogle Scholar
• Mathis D, Benoist C. Aire. Annu Rev Immunol. 2009;27: 287–312.
   PubMed Web of Science ®Google Scholar
• Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol. 2009;21:281–5.
   PubMed Web of Science ®Google Scholar
• Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med. 2000;6:56–61.
   PubMed Web of Science ®Google Scholar
• Harrington CJ, Paez A, Hunkapiller T, Mannikko V, Brabb T, Ahearn M, . Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity. 1998;8:571–80.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;89:12–19.
   Web of Science ®Google Scholar
• Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, . Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278–85.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907.
   PubMed Web of Science ®Google Scholar
• D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356: 1944–56.
   PubMed Web of Science ®Google Scholar
• Harper DM. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health. Public Health Genomics. 2009;12:319–30.
   PubMed Web of Science ®Google Scholar
• Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781–9.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Jin F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health. 2010;7:244–52.
   PubMed Web of Science ®Google Scholar
• Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, . Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797–801.
   PubMed Web of Science ®Google Scholar
• Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, ; Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 1997;336:1855–9.
   PubMed Web of Science ®Google Scholar
• West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine. 1996;14:1019–27.
   PubMed Web of Science ®Google Scholar
• Pattle SB, Farrell PJ. The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther. 2006;6:1193–205.
   PubMed Web of Science ®Google Scholar
• Beral V, Newton R, Sitas F. Human Herpesvirus 8 and Cancer. J Nat Cancer Inst. 1999;91:1440–1.
   PubMed Web of Science ®Google Scholar
• Franchini G, Nicot C, Johnson JM. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res. 2003;89:69–132.
   PubMed Web of Science ®Google Scholar
• Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, . An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A. 2007;104:1655–60.
   PubMed Web of Science ®Google Scholar
• Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A. 2009;106:16351–6.
   PubMed Web of Science ®Google Scholar
• Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, . XMRV: a new virus in prostate cancer? Cancer Res. 2010;70:10028–33.
   PubMed Web of Science ®Google Scholar
• Stoye JP, Silverman RH, Boucher CA, Le Grice SF. The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop. Retrovirology. 2010;7:113.
   PubMedGoogle Scholar
• Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, . Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.
   PubMed Web of Science ®Google Scholar
• Ponta H, Gonzburg WH, Salmons B, Groner B, Herrlich P. Mouse mammary tumour virus: A proviral gene contributes to the understanding of eukaryotic gene expres-sion and mammary tumorigenesis. J Gen Virol. 1985;66:931–43.
   PubMedGoogle Scholar
• Holland JF, Pogo BG. Mouse mammary tumor virus-like viral infection and human breast cancer. Clin Cancer Res. 2004;10:5647–9.
   PubMed Web of Science ®Google Scholar
• Pogo BG, Holland JF, Levine PH. Human mammary tumor virus in inflammatory breast cancer. Cancer. 2010;116(11 Suppl):2741–4.
   PubMedGoogle Scholar
• Szabo S, Haislip AM, Traina-Dorge V, Costin JM, Crawford BE 2nd, Wilson RB, . Human, rhesus macaque, and feline sequences highly similar to mouse mammary tumorvirus sequences. Microsc Res Tech. 2005;68:209–21.
   PubMed Web of Science ®Google Scholar
• Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, . Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol. 2008;82:9329–36.
   PubMed Web of Science ®Google Scholar
• Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, . Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 2008;10:521–33.
   PubMed Web of Science ®Google Scholar
• Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, . Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 2008;68:5869–77.
   Google Scholar
• Stewart TH, Sage RD, Stewart AF, Cameron DW. Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus. Br J Cancer. 2000;82:446–51.
   PubMed Web of Science ®Google Scholar
• Indik S, Günzburg WH, Salmons B, Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res. 2005;65:6651–9.
   PubMedGoogle Scholar
• Rollison DE. JC Virus infection a cause of colorectal cancer? J Clin Gastroent. 2010;44:466–8.
   PubMedGoogle Scholar
• Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med. 2010;16:799–803.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer, World Health Organizaion, GLOBOCAN 2008. Breast cancer incidence and mortality worldwide in 2008. Available at: http://globocan.iarc.fr/factsheets/cancers/breast.asp#MORTALITY (Last accessed 11 March 2011).
   Google Scholar
• Hall L, Craig RK, Davies MS, Ralphs DN, Campbell PN. α-Lactalbumin is not a marker of human hormone-dependent breast cancer. Nature. 1981;290:602–4.
   PubMedGoogle Scholar
• Bailey AJ, Sloane JP, Trickey BS, Ormerod MG. An immunocytochemical study of α-lactalbumin in human breast tissue. J Pathol. 1982;137:13–23.
   PubMed Web of Science ®Google Scholar
• Clayton F, Sibley RK, Ordonez NG, Hanssen G. Argyrophilic breast carcinomas: evidence of lactational differentiation. Am J Surg Pathol. 1982;6:323–33.
   PubMed Web of Science ®Google Scholar
• Lee AK, DeLellis RA, Rosen PP, Herbert-Stanton T, Tallberg K, Garcia C, . Alpha-lactalbumin as an immunohistochemical marker for metastatic breast carcinomas. Am J Surg Pathol. 1984;8:93–100.
   PubMed Web of Science ®Google Scholar
• Lee AK, Rosen PP, DeLellis RA, Saigo PE, Gangi MD, Groshen S, . Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am J Clin Pathol. 1985;84:687–96.
   PubMedGoogle Scholar
• Cohen C, Sharkey FE, Shulman G, Uthman EO, Budgeon LR. Tumor associated antigens in breast carcinomas. Prognostic significance. Cancer. 1987;60:1294–8.
   PubMedGoogle Scholar
• Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G, Spona J. Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract. 1988; 183:277–83.
   PubMedGoogle Scholar
• Martin RH, Glass MR, Chapman C, Wilson GD, Woods KL. Suppression by bromocriptine of the serum lactalbumin peak associated with human lactogenesis. Clin Endocrinol (Oxf). 1981;14:363–6.
   PubMedGoogle Scholar
• Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, . Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter. Mol Cancer Ther. 2005;4:1850–9.
   PubMed Web of Science ®Google Scholar
• Anderson LM, Swaminathan S, Zackon I, Tajuddin AK, Thimmapaya B, Weitzman SA. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer. Gene Ther. 1999;6:854–64.
   PubMedGoogle Scholar
• Anderson LM, Krotz S, Weitzman SA, Thimmapaya B. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Cancer Gene Ther. 2000;7:845–52.
   PubMed Web of Science ®Google Scholar
• Nagamatsu Y, Oka T. Purification and characterization of mouse α-lactalbumin and preparation of its antibody. Biochem J. 1980;185:227–37.
   PubMedGoogle Scholar
• Ren J, Stuart DI, Acharya KR. α-lactalbumin possesses a distinct zinc binding site. J Biol Chem. 1993;268:19292–8.
   PubMedGoogle Scholar
• Vilotte JL, Soulier S. Isolation and characterization of the mouse α-lactalbumin-encoding gene: interspecies comparison, tissue-and stage-specific expression. Gene. 1992;119:287–92.
   PubMedGoogle Scholar
• Vilotte JL, Soulier S, Mercier JC. Sequence of the murine α-lactalbumin-encoding cDNA: interspecies comparison of the coding frame and deduced preprotein. Gene. 1992; 112:251–5.
   PubMed Web of Science ®Google Scholar
• Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A. 1992;89:10578–82.
   PubMed Web of Science ®Google Scholar
• Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992;12:954–61.
   PubMed Web of Science ®Google Scholar